CANNABIS STRAINS
Blue Dream × Master Kush indica-dominant hybrid. Relaxed body high with creative mental clarity — the daytime indica that doesn’t lock you to the couch.
Snoop’s Dream is a cross between Blue Dream (Blueberry × Haze) and Master Kush (Hindu Kush × Skunk #1 lineage), developed in association with Snoop Dogg’s cannabis brand. The pairing was deliberate: Blue Dream contributes the cerebral, euphoric sativa character that made it the best-selling strain in dispensaries across California and Colorado for several consecutive years, while Master Kush adds the dense body relaxation, resinous structure, and hash-forward aromatics typical of Hindu Kush descendants.
The result sits in a sweet spot that indica enthusiasts and sativa-leaning consumers both find accessible. The sativa genes from Haze keep cognitive function largely intact at moderate doses, preventing the heavy mental fog seen in pure kush expressions. Breeders selecting for commercial appeal found that retaining 20–30% sativa expression in the phenotype improved daytime usability without sacrificing the indica body effect consumers sought.
| Attribute | Blue Dream | Master Kush | Snoop’s Dream |
|---|---|---|---|
| Lineage | Blueberry × Haze | Hindu Kush × Skunk | Blue Dream × Master Kush |
| Dominant Type | Sativa-dominant hybrid | Indica | Indica-dominant hybrid |
| THC Range | 17–24% | 20–24% | 18–23% |
| Primary Aroma | Blueberry, sweet, vanilla | Earthy, hash, citrus | Blueberry, pine, earthy |
| Dominant Effect | Uplifted, creative, energetic | Relaxed, sedated, happy | Relaxed, creative, uplifted |
| Couch-Lock Risk | Low | High | Low–Moderate |
| Flower Time | 9–10 weeks | 8–9 weeks | 8–9 weeks |
| Grow Difficulty | Easy–Moderate | Easy | Moderate |
Laboratory testing across multiple cultivators consistently places Snoop’s Dream between 18% and 23% total THC, with most commercial cuts averaging 20–21%. CBD content is negligible (below 0.5%), and CBG is typically present at 0.3–0.8%, contributing mild anti-inflammatory and neuroprotective effects. The terpene suite is dominated by myrcene, which explains both the earthy musk in the aroma and the pronounced physical relaxation that distinguishes it from pure Blue Dream phenotypes.
| Compound | Typical Range | Function / Effect Contribution |
|---|---|---|
| THC (total) | 18–23% | Primary psychoactive; euphoria, pain relief, appetite |
| CBD | <0.5% | Minimal anxiolytic modulation at these levels |
| CBG | 0.3–0.8% | Anti-inflammatory, neuroprotective, appetite modulation |
| CBN | <0.2% | Minor sedative contribution in aged material |
| Myrcene | 0.4–0.9% | Earthy musk; enhances CB1 binding permeability; sedative body effect |
| Beta-Pinene | 0.2–0.5% | Pine, fresh; bronchodilator; may counter short-term memory impairment |
| Beta-Caryophyllene | 0.15–0.35% | Spice, pepper; CB2 agonist; anti-inflammatory, stress reduction |
| Limonene | 0.05–0.15% | Citrus lift; mood elevation, stress modulation |
| Linalool | 0.03–0.10% | Floral note; GABAergic calming effect; anxiety reduction |
Understanding how Snoop’s Dream unfolds over time helps users calibrate timing and dosing effectively. The experience divides clearly into three phases influenced by its dual lineage.
Phase 1 (0–15 minutes): The Blue Dream genetics activate first. Users report a gentle cerebral pressure behind the eyes, followed by a spreading warmth in the temples. Mood lifts quickly into euphoria and sociability. Creative associations feel more accessible than baseline, making this phase ideal for artistic work, brainstorming, or conversation.
Phase 2 (15–60 minutes): Master Kush genes come forward. A progressive muscle relaxation moves from the neck and shoulders downward. Physical discomfort diminishes. Despite the body effect, most users at moderate doses (0.2–0.4g flower or equivalent) remain mentally engaged and conversational. The psychoactive ceiling feels manageable rather than overwhelming.
Phase 3 (60–180 minutes): As the high plateaus and begins to descend, sedation increases slightly. Users predisposed to indica sensitivity may find themselves ready to sleep during this phase, especially at higher doses. Most report a smooth comedown without anxiety or dysphoria, a direct benefit of the linalool and caryophyllene content moderating the THC intensity.
| Time of Day | Suitability | Recommended Activities | Cautions |
|---|---|---|---|
| Morning (6am–12pm) | Moderate | Creative work, yoga, light exercise, social breakfast | Avoid if driving or demanding cognition required |
| Afternoon (12pm–5pm) | High | Music, art, writing, casual social settings, nature walks | Low risk; optimal window for most users |
| Early Evening (5pm–8pm) | High | Dinner, film, conversation, light physical activity | Dose lower if planning to drive later |
| Late Evening (8pm–11pm) | Moderate | Winding down, watching films, reading | Higher doses may cause early sleep onset |
| Night (11pm+) | Low–Moderate | Sleep aid at higher doses | Not a primary sleep strain; use indica-only strains for insomnia |
Snoop’s Dream occupies a productive middle ground for medical cannabis patients: potent enough to address genuine physical discomfort, yet gentle enough to remain functional during treatment hours. The combination of myrcene and beta-caryophyllene provides physical analgesia through two complementary mechanisms — myrcene enhancing blood-brain barrier permeability and CB1 engagement, caryophyllene working peripherally via CB2 receptors to reduce pro-inflammatory cytokine signalling.
A 2019 retrospective analysis published in the Journal of Affective Disorders (Turna et al.) found that cannabis strains with significant myrcene content scored highest on patient-reported anxiety and depression relief relative to single-terpene preparations. While no studies focus specifically on Snoop’s Dream, its terpene architecture closely mirrors the profiles examined in that research.
Reported medical uses include: stress and generalised anxiety (the caryophyllene + linalool combination calms the amygdala response without the sedation of pure indicas); depression (Blue Dream genetics maintain dopaminergic uplift throughout the session); mild to moderate pain (muscle tension, headaches, menstrual pain respond well); appetite stimulation (THC-driven munchies arrive reliably in Phase 2); and fatigue management (the sativa fraction keeps motivation intact at lower doses).
Patients with anxiety sensitivity should start with 5mg THC or less and avoid high-dose sessions. The low CBD content means there is minimal buffer against THC-induced anxiety at high intake levels.
Snoop’s Dream is a rewarding grow for cultivators with some prior experience. The plant inherits structural traits from both parents: Blue Dream contributes taller, more branchy vegetative growth, while Master Kush compresses the node spacing and increases resin density. The finished plant is medium-tall with dense, sticky buds that benefit from adequate airflow to prevent mould in the final weeks.
The strain responds exceptionally well to LST (low-stress training) and ScrOG setups. By spreading the canopy during the first 3–4 weeks of vegetation, growers can dramatically increase light penetration to lower bud sites and push yields toward the upper end of the range. Topping at the third or fourth node during veg is standard practice for commercial cultivators.
| Parameter | Indoor | Outdoor |
|---|---|---|
| Flower Time | 8–9 weeks | Late September – early October |
| Yield | 450–550 g/m² | 500–700 g/plant |
| Height | 80–120 cm (trained) | 150–200 cm |
| Difficulty | Moderate | Moderate |
| Optimal Temp | 20–26°C veg; 18–24°C flower | Mediterranean or temperate climate preferred |
| Humidity | 50–70% RH veg; 40–50% RH flower | Avoid humid autumn climates; mould risk in final weeks |
| Feeding | Moderate N in veg; P/K heavy in flower weeks 4–7 | Well-amended organic soil; minimal additional feeding |
| Training | LST, topping, ScrOG all effective | Light topping; full-canopy develops naturally |
| Harvest Indicator | 70% cloudy / 30% amber trichomes for peak THC | Same trichome ratio; watch for pistil colour change |
Few hybrid strains present such a clearly delineated two-parent aroma as Snoop’s Dream. The olfactory profile breaks into three distinct registers. On initial jar opening, sweet blueberry and mixed berry fruit notes dominate — a direct inheritance from the Blueberry phenotype that underpins Blue Dream. Underneath this fruit layer sits the earthier, hashish-forward character of Master Kush: dry soil, old wood, and faint incense. A third register of fresh pine resin sharpens the bouquet and prevents the hash notes from becoming overpowering.
The smoke and vapour are characteristically smooth for an indica hybrid. Master Kush genetics eliminate the Haze harshness that can irritate throats in Blue Dream-heavy phenotypes. The exhale reveals the full pine-blueberry interplay, with a faint diesel accent that lingers several minutes after the session. Dry herb vaporisation at 185–195°C best preserves the full terpene expression; combustion accelerates myrcene oxidation and slightly flattens the blueberry note.
Snoop’s Dream is an indica-dominant hybrid (Blue Dream × Master Kush) created in association with Snoop Dogg’s cannabis brand. THC ranges 18–23%. It delivers creative, uplifted euphoria with progressive body relaxation and smooth smoke.
At moderate doses (under 0.4g flower or 10mg THC equivalent), couch-lock is uncommon. The Blue Dream genetics maintain cerebral function throughout most of the session. Heavy dosing, however, will trigger significant sedation in the final phase of the experience.
When smoked or vaped, the high typically lasts 2–3 hours, with peak effects in the 30–90 minute window. Edibles extend duration to 4–6 hours with a stronger body component due to 11-hydroxy-THC conversion in the liver.
In low-to-moderate doses, yes. Beta-caryophyllene and linalool both have documented anxiolytic activity, and the euphoric sativa component lifts mood without inducing paranoia in most users. Anxiety-prone individuals should avoid high doses and consider a 1:1 THC:CBD product for extra safety margin.
Snoop’s Dream flowers in 8–9 weeks indoors. Outdoor harvests fall in late September to early October in the Northern Hemisphere. Full seed-to-harvest for an indoor grow with a 4-week vegetative stage is approximately 12–13 weeks.